Evolution of the Average Target: GSK plc

Evolution of the Average Target - GSK plc

Evolution of the Target Price: GSK plc

Evolution of the Target Price - GSK plc

Changes in Analyst Recommendations: GSK plc

b6e3d67ccf32d33.DrarWA7SXygDBEwK0SvrBIa57DPpiWdRp_AzKc5ErUM.YIbmKnvna2swSnRMqBuoT-PjiwKr2SU-xbYFaIkt4Q1p2Z03SLtnWmEyJw~dcebbe62660f5d8ef5000a74a248f89e
10-15 GSK plc : UBS remains Neutral ZD
10-14 Berenberg still a buyer of GSK, considering stock undervalued Zonebourse
10-14 GSK plc : Berenberg remains its Buy rating ZD
10-14 GSK's Pharma Business to Drive Future Returns Amid Oncology Boost, Berenberg Says MT
10-14 RBC Expects 'In-line' Q3 Results for GSK as Strong HIV, Asthma Drug Sales Offset Vaccine Softness MT
10-13 GSK Likely to Deliver In-Line Q3, RBC Says MT
10-13 GSK plc : RBC gives a Neutral rating ZD
10-08 GSK plc : Gets a Sell rating from JP Morgan ZD
10-07 GSK plc : Berenberg remains its Buy rating ZD
10-01 GSK plc : JP Morgan reiterates its Sell rating ZD
09-29 GSK plc : Gets a Neutral rating from Deutsche Bank ZD
09-29 GSK plc : Jefferies keeps its Buy rating ZD
09-18 GSK plc : Deutsche Bank remains Neutral ZD
09-17 GSK plc : UBS is Neutral ZD
09-16 AlphaValue/Baader Europe Notes GSK's Plans to Address Upcoming Patent Cliff; Price Target Down MT
09-15 GSK plc: Priced for the storm, being built for thereafter Alphavalue
09-15 GSK Upgraded to Buy as Berenberg Notes Pipeline Momentum; Price Target Raised MT
09-15 Berenberg Upgrades GSK to Buy, Raises PT MT
09-15 Berenberg Upgrades GSK to Buy From Hold, Raises Price Target to $60 From $54 MT
09-15 Berenberg likes GSK; Deutsche Bank lifts Astra AN
09-15 GSK plc : Deutsche Bank remains Neutral ZD
09-15 GSK plc : Berenberg gives a Buy rating ZD
09-14 GSK plc : Gets a Sell rating from JP Morgan ZD
09-14 GSK plc : JP Morgan reiterates its Sell rating ZD
09-14 GSK plc : Jefferies keeps its Buy rating ZD

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+16.29%
+6.11%
+10.32%
-0.28%
+9.26%
-0.65%
-1.09%
+24.17%
-9%
+1.57%
Average +5.67%
Weighted average by Cap. +5.43%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
18.68GBP
Average target price
21.73GBP
Spread / Average Target
+16.29%
High Price Target
30.10GBP
Spread / Highest target
+61.09%
Low Price Target
14.55GBP
Spread / Lowest Target
-22.13%

Analyst Consensus Detail

Analyst consensus - GSK plc

Consensus revision (last 18 months)

Consensus revision (last 18 months) - GSK plc
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - GSK plc